Research Experience
Honorary Fellow at the School of Life Sciences Department, Essex University, Aug 2025-present
Projects:
- The p90 Ribosomal S6 Kinases 2 and 4 promote Prostate Cancer cell proliferation in androgen-dependent and independent ways
- Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer
- Inhibition of porphyrin synthesis selectively sensitises prostate cancer cells to ROS damage and promotes caspase-independent cell death
Specialist Technician at the School of Life Sciences Department, Essex University, May 2023-Jul 2023
Projects:
- Analysis of coding gene expression from small RNA sequencing
Publications
Preprint
- Azadova, A., Ekperuoh, A., Brooke, G.N. and Marco, A., 2024. Analysis of coding gene expression from small RNA sequencing. bioRxiv, pp.2024-06.
- Cronin, R., Azadova, A., Marco, A., Laissue, P.P., Brooke, G.N. and Prischi, F., 2024. The p90 Ribosomal S6 Kinases 2 and 4 promote Prostate Cancer cell proliferation in androgen-dependent and independent ways. bioRxiv, pp.2024-03.
- Brooke, G., Culley, R., Leach, D., Latonen, L., Rees, E., Alkheilewi, M., Pine, A., Fioretti, F., Reader, C., Azadova, A. and Powell, S., 2025. Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer.
Conference material
- Azadova, A., Brooke, G. and Marco, A., 2024. Abstract LB335: Steroid receptor cross-talk in breast cancer. Cancer Research, 84(7_Supplement), pp.LB335-LB335.
Working papers
- Allafi A., Rees E., Khalaj R., Azadova A., Mohr A., Zwazka R., Laissue P., Brooke G. N. “Inhibition of porphyrin synthesis selectively sensitises prostate cancer cells to ROS damage and promotes caspase-independent cell death”
- Azadova A., Brooke G., Isayev O. “Oestrogen regulation of Notch signalling pathway in breast cancer”
- Azadova A., Brooke G. N. , Marco A. “The role of Oestrogen Receptor-𝛼 (ER𝛼) crosstalk with Mineralocorticoid Receptor in breast cancer”
© 2025 Aygun Azadova. All rights reserved.
LinkedIn